View Amendment Current Amendment: 1 to Bill 4602 The Committee on Medical, Military, Public and Municipal Affairs proposes the following Amendment No. 1 to H. 4602 (COUNCIL\VR\4602C001.CC.VR18):

Reference is to Printer's Date 1/10/18-H.

Amend the bill, as and if amended, by striking SECTION 1 and inserting:

/      SECTION      1.      Chapter 130, Title 44 of the 1976 Code is amended by adding:

     "Section 44-130-70.      (A)      If a person is administered an opioid antidote in a hospital emergency department or other health care facility and the supervising physician diagnoses the patient as having experienced an opioid overdose, the supervising physician, the supervising physician's authorized delegate, or the institutional pharmacy's pharmacist-in-charge shall report to the department's Bureau of Drug Control information regarding the opioid antidote administered for inclusion in the prescription monitoring program. The information submitted must include:
           (1)      date the opioid antidote was administered;
           (2)      dosage of opioid antidote administered and route of administration; and
           (3)      name, address, and date of birth of the person to whom the opioid antidote was administered, if available.
     (B)      The supervising physician, the supervising physician's authorized delegate, or the institutional pharmacy's pharmacist-in-charge shall submit the information required pursuant to subsection (A) electronically to Drug Control within three business days after a discharge diagnosis of an opioid overdose and administration of an opioid antidote.
     (C)(1)      After a supervising physician, the supervising physician's authorized delegate, or the institutional pharmacy's pharmacist-in-charge submits the name, address, and date of birth of a person to whom an opioid antidote was administered as required by subsection (A), Drug Control shall verify whether any prescription history of the person appears in the prescription monitoring program and, if prescription history exists, shall document for review by a practitioner or an authorized delegate the date on which the opioid antidote was administered to the person.
           (2)      Drug Control also shall maintain data on the administering of opioid antidotes as required by this section including, but not limited to, the frequency with which opioid antidotes are administered in hospital emergency departments as required pursuant to subsection (A) and other health care facilities by geographic location."      /

Renumber sections to conform.
Amend title to conform.